Skip to main content

Market Overview

Zynerba Pharmaceuticals (NASDAQ: ZYNE)

3.97 -0.06 (-1.49%)

Earnings

QuarterPriorEstimateActualSurprise
Q4 2021
Pre-Market
EPS:
REV:
-0.33
0



Q3 2021
Pre-Market
EPS:
REV:
-0.31
0



Q2 2021
Pre-Market
EPS:
REV:
-0.78
0



Q1 2021
Pre-Market
EPS:
REV:
-0.53
0



Q4 2020
Pre-Market
EPS:
REV:
-0.46
0
-0.32
-0.33
0
-3.12%
Q3 2020
Pre-Market
EPS:
REV:
-0.08
0
-0.43
-0.31
0
27.91%
Q2 2020
Pre-Market
EPS:
REV:
-0.50
0
-0.45
-0.78
0
-73.33%
Q1 2020
Pre-Market
EPS:
REV:
-0.47
0
-0.50
-0.53
0
-6%
Q4 2019
Pre-Market
EPS:
REV:
-0.44
86K
-0.50
-0.46
0
8%
Q3 2019
Pre-Market
EPS:
REV:
-0.47

-0.08
0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!